A fresh crop of shareholder proposals that would have once been unremarkable are now a closely-watched battlefront in the war ...

That law firm is leading litigation against Merck’s HPV vaccine ... The findings: In 2021 and 2022, the maternal death rate for Black women was roughly 2.6 times higher than for white women. In 2023, ...

The Pharmaceutical ... 56% of Black Americans and 60% of Hispanic Americans surveyed were subject to utilisation management practices, compared to just 36% of white Americans.

and 1.8 times higher among black compared to white adults. "This initiative will give us better insights into the cardiovascular health of New Yorkers in an effort to identify the most pressing ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Neuphoria Therapeutics said it expects to receive a milestone payment from Merck for the second clinical trial phase of its Alzheimer's disease dementia treatment.

With yet another quarter where Pfizer handily beat consensus earnings expectations, it’s even more clear that CEO Albert Bourla is already well on his way toward getting Pfizer back on track ...

(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") ...

Co's stock has reached a 52-week low, dipping to $85.71. This downturn reflects a significant shift from the previous year, with the pharmaceutical giant experiencing a 1-year change of -31.59%.

WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...